Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Camlin Fine Sciences Ltd Regulatory Filings 2021

Jun 22, 2021

59255_rns_2021-06-22_3baae1de-b51c-46ce-98a1-e0362b39e1d7.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [100 x 31] intentionally omitted <==

22[nd] June, 2021

||To,BSE Limited,25, P. J. Towers,Dalal Street,Mumbai – 400 001**Ref:**Company Scrip Code: 532834|To,The Manager,Listing Department,National Stock Exchange of India Ltd.,Exchange Plaza, Bandra Kurla Complex,Bandra (East), Mumbai‐ 400051**Ref:Symbol:**CAMLINFINE||Series: EQ| |---|---|---|

Sub: Intimation for withdrawal of rating assigned with respect to the bank facilities on the request of the Company.

This is to inform you that on the request of the Company for voluntary withdrawal of credit rating with respect to its bank facilities of INR 392.30 crores (the “said facilities), Acuité Ratings & Research Limited (“Acuité”) has, withdrawn its rating on the said facilities, effective from June 18, 2021. The rating issued by Acuité at the time of withdrawal remains unchanged from what Acuité had issued earlier, i.e. long‐ term rating of ‘ACUITE A‐’ (read as ACUITE A minus) and short‐term rating of ‘ACUITE A2+’ (read as ACUITE A two plus). The outlook also remains “stable”.

The withdrawal letter was issued by Acuité on June 18, 2021 which was received by the Company on June 21, 2021.

You are requested to take the above information on record.

For Camlin Fine Sciences Limited

==> picture [55 x 52] intentionally omitted <==

==> picture [83 x 35] intentionally omitted <==

Mr. Mandar Godbole GM Legal & Company Secretary (Membership No – 30240)

==> picture [426 x 57] intentionally omitted <==